These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20810130)

  • 21. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HLA locus and multiple sclerosis in Sicily.
    Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
    Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis.
    Shahbazi M; Roshandel D; Ebadi H; Fathi D; Zamani M; Boghaee M; Mohammadhoseeeni M; Rshaidbaghan A; Bakhshandeh A; Shahbazi S
    Clin Immunol; 2010 Oct; 137(1):134-8. PubMed ID: 20594918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
    Handel AE; De Luca GC; Morahan J; Handunnetthi L; Sadovnick AD; Ebers GC; Ramagopalan SV
    J Neuroimmunol; 2010 Jun; 223(1-2):120-3. PubMed ID: 20394989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
    Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
    Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
    Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
    Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Zacchi T; Nasuelli D; Ukmar M; Furlan C; Pozzi-Mucelli R; Tommasi MA; Locatelli L; Ulivi S; Bratina A; Bosco A; Grop A; Cazzato G; Zorzon M
    J Neurol; 2003 Sep; 250(9):1099-106. PubMed ID: 14504973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
    Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
    Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
    Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
    Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.
    Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T
    Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
    Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
    Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
    Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
    Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
    Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
    Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis.
    Buck D; Cepok S; Hoffmann S; Grummel V; Jochim A; Berthele A; Hartung HP; Wassmuth R; Hemmer B
    Arch Neurol; 2011 Apr; 68(4):480-7. PubMed ID: 21482927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population.
    Shahbazi M; Ebadi H; Fathi D; Roshandel D; Mohamadhosseni M; Tahmasebi A; Shahbazi S; Zamani M; Rashidbaghan A
    Mult Scler; 2010 Oct; 16(10):1173-7. PubMed ID: 20685768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.